ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
2,1,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
2,2,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
4,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
5,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
6,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
7,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
7,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
7,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
10,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12,3,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12,4,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
12,5,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
12,6,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
12,7,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
12,8,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
12,9,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
12,10,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
12,11,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
12,12,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
12,13,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
12,14,Brain stem glioma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
12,15,Brain stem glioma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
12,16,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,17,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
12,18,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
12,19,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
12,20,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
12,21,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
12,22,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12,23,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
12,24,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
12,25,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
12,26,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
12,27,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
12,28,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,29,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
12,30,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12,31,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
12,32,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12,33,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,34,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,35,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
12,36,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
12,37,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12,38,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
12,39,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
12,40,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
13,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
14,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
14,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,3,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
14,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,5,Staphylococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
15,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,1,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
16,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
16,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
